Profil
Nicholas Williams is currently a Board Director at Alderaan Biotechnology SAS, a Non-Executive Director at Versanis Bio, Inc., and a Partner at Medicxi Ventures (Jersey) Ltd. He graduated from the University of Cardiff.
Postes actifs de Nicholas Williams
| Sociétés | Poste | Début |
|---|---|---|
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi invests in biopharma companies located in Europe. The firm provides financing for early and late stage capital requirements. | Analyste en capital-investissement | - |
Versanis Bio, Inc.
Versanis Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Directeur/Membre du Conseil | - |
Alderaan Biotechnology SAS
Alderaan Biotechnology SAS BiotechnologyHealth Technology Operates as preclinical stage company for monoclonal antibodies development for the treatment of cancer | Directeur/Membre du Conseil | - |
Formation de Nicholas Williams
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Cardiff
University of Cardiff Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medicxi Ventures (Jersey) Ltd.
Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi invests in biopharma companies located in Europe. The firm provides financing for early and late stage capital requirements. | Finance |
Alderaan Biotechnology SAS
Alderaan Biotechnology SAS BiotechnologyHealth Technology Operates as preclinical stage company for monoclonal antibodies development for the treatment of cancer | Health Technology |
Versanis Bio, Inc.
Versanis Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
















